KIR3DL1 and acute myeloid leukemia: The clinical contribution of NK cells to alloreactivity was impressively shown by Ruggeri et al. (2002) who demonstrated a strong GvL effect for AML patients receiving a haploidentical allogeneic transplant mismatched for HLA-C KIR ligands.